Enhanc3d Genomics Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Enhanc3d Genomics Ltd - overview
Established
2020
Location
Cambridge, -, UK
Primary Industry
Biotechnology
About
Based in Cambridge, UK, and incorporated in 2020, Enhanc3d Genomics Ltd operates as a biotechnology research platform that uses machine learning to discover and develop biological diseases. In September 2025, Enhanc3d Genomics Ltd raised GBP 6. 1 million in series A funding from new investor Meltwind Advisory, with participation from returning investors BGF Investment Management, Bioqube Ventures and Parkwalk Advisors. Other unspecified investors also participated in the round.
The round was part of larger GBP 15 million in series A funding. The company works on a new application to improve human healthcare. It uses machine learning to enhance the potential of 3D genomics by linking genes enhancers and non-coding genetic variants. The technology used by the firm includes artificial intelligence driver functional modeling, whole-genome 3D structure mapping, GenLink 3D Platform, etc.
Enhanc3d Genomics Ltd earns revenue by licensing validated drug targets, partnering with pharma for discovery programs, and developing proprietary therapeutics using its 3D multi-omics platform. The company will use the September 2025 funding to support the further development of its internal therapeutic pipeline.
Current Investors
Start Codon, Bioqube Ventures, Johnson & Johnson Innovation
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.enhancedgenomics.com/
Verticals
3D Printing, Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.